0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Drug/Vaccine Safety
 21-40 of 572 Articles
JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Valérie Boige, MD, PhD; Marc Vincent, PhD; Philippe Alexandre, MS; et al.
JAMA Oncol. Published online January 21, 2016. doi:10.1001/jamaoncol.2015.5392
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Nicholas D. James, PhD, FRCR, FRCP; Sarah J. Pirrie, MSc; Ann M. Pope, PhD; et al.
JAMA Oncol. Published online January 21, 2016. doi:10.1001/jamaoncol.2015.5570
Includes: Supplemental Content

JAMA Dermatology | 
Viewpoint |  ONLINE FIRST
Kenneth A. Katz, MD, MSc, MSCE
JAMA Dermatol. Published online January 13, 2016. doi:10.1001/jamadermatol.2015.5547

JAMA Pediatrics | 
Viewpoint |  ONLINE FIRST
Adam L. Hersh, MD, PhD; Jason G. Newland, MD, MEd; Jeffrey S. Gerber, MD, PhD
JAMA Pediatr. Published online January 11, 2016. doi:10.1001/jamapediatrics.2015.3369

JAMA Internal Medicine | 
Viewpoint | 
Anna Hung, PharmD; Jan Sieluk, MPharm; Peter Doshi, PhD
JAMA Intern Med. 2016;176(1):11-12. doi:10.1001/jamainternmed.2015.6656.

JAMA Oncology | 
Research Letter | 
Charles L. Bennett, MD, PhD, MPP; Stephen Y. Lai, MD, PhD; Oliver Sartor, MD; et al.
JAMA Oncol. 2016;2(1):134-136. doi:10.1001/jamaoncol.2015.3940.

JAMA Internal Medicine | 
Research Letter | 
Alberto Maino, MD; Bob Siegerink, PhD; Ale Algra, MD, PhD; et al.
JAMA Intern Med. 2016;176(1):134-136. doi:10.1001/jamainternmed.2015.6523.

JAMA Psychiatry | 
Original Investigation | 
Dale C. Hesdorffer, PhD; Lianna Ishihara, PhD; David J. Webb, MSc; et al.
JAMA Psychiatry. 2016;73(1):80-86. doi:10.1001/jamapsychiatry.2015.2516.
Includes: Supplemental Content

JAMA Dermatology | 
Original Investigation | 
Vassiliki Tzanetakou, MD; Theodora Kanni, MD; Sophia Giatrakou, MD; et al.
JAMA Dermatol. 2016;152(1):52-59. doi:10.1001/jamadermatol.2015.3903.
Includes: Supplemental Content

JAMA Oncology | 
Editorial | 
Gérard Milano, PhD; Emmanuel Chamorey, PharmD, PhD; Jean-Marc Ferrero, MD, PhD
JAMA Oncol. 2016;2(1):21-22. doi:10.1001/jamaoncol.2015.3866.

JAMA Oncology | 
Original Investigation | 
Chau Dang, MD; Hao Guo, MS; Julie Najita, PhD; et al.
JAMA Oncol. 2016;2(1):29-36. doi:10.1001/jamaoncol.2015.3709.
Includes: Supplemental Content

JAMA Neurology | 
Original Investigation | 
Ying Xian, MD, PhD; Jerome J. Federspiel, MD, PhD; Maria Grau-Sepulveda, MD, MPH; et al.
JAMA Neurol. 2016;73(1):50-59. doi:10.1001/jamaneurol.2015.3106.
Includes: Supplemental Content

JAMA Internal Medicine | 
Invited Commentary | 
Chester B. Good, MD, MPH; Walid F. Gellad, MD, MPH
JAMA Intern Med. 2016;176(1):63-64. doi:10.1001/jamainternmed.2015.6068.

JAMA Internal Medicine | 
Original Investigation | 
Tewodros Eguale, MD, PhD; David L. Buckeridge, MD, PhD; Aman Verma, PhD; et al.
JAMA Intern Med. 2016;176(1):55-63. doi:10.1001/jamainternmed.2015.6058.
Includes: Supplemental Content

JAMA Oncology | 
Editor's Note |  FREE
Howard (Jack) West, MD
JAMA Oncol. 2016;2(1):122. doi:10.1001/jamaoncol.2015.4126.

JAMA Dermatology | 
Observation |  ONLINE FIRST
Lara Valeska Maul, MD; Katharina C. Kähler, MD; Axel Hauschild, MD
JAMA Dermatol. Published online December 30, 2015. doi:10.1001/jamadermatol.2015.4592

JAMA Oncology | 
Editorial |  ONLINE FIRST
Michael Kolinsky, BSc, MD; Pasquale Rescigno, MD; Johann S. de Bono, MB, ChB, MSc, FRCP, PhD, FMedSci
JAMA Oncol. Published online December 23, 2015. doi:10.1001/jamaoncol.2015.4918

JAMA Oncology | 
Invited Commentary |  ONLINE FIRST
Saroj Niraula, MBBS, MD, MSc; Ian F. Tannock, MD, PhD
JAMA Oncol. Published online December 23, 2015. doi:10.1001/jamaoncol.2015.4682

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Dawn L. Hershman, MD, MS; Joseph M. Unger, PhD; Jason D. Wright, MD; et al.
JAMA Oncol. Published online December 23, 2015. doi:10.1001/jamaoncol.2015.4655
Includes: Supplemental Content

JAMA Dermatology | 
Editorial |  ONLINE FIRST
Matthew H. Kanzler, MD
JAMA Dermatol. Published online December 23, 2015. doi:10.1001/jamadermatol.2015.4203

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Original Investigation  | 
Association Between BCR-ABL Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia and Cardiovascular Events, Major Molecular Response, and Overall Survival A Systematic Review and Meta-analysis
Jonathan Douxfils, PharmD, PhD; Hélène Haguet, MBS; François Mullier, PharmD, PhD; et al.
JAMA Oncology
Review  | 
Toxic Effects of Sorafenib in Patients With Differentiated Thyroid Carcinoma Compared With Other Cancers
Gary W. Jean, PharmD; Rene M. Mani, PharmD; Aliza Jaffry, PharmD; et al.
JAMA
From The Medical Letter on Drugs and Therapeutics  | 
Drugs Past Their Expiration Date

JAMA Dermatology
Original Investigation  | 
Risk of Nonmelanoma Skin Cancer Associated With the Use of Immunosuppressant and Biologic Agents in Patients With a History of Autoimmune Disease and Nonmelanoma Skin Cancer
Frank I. Scott, MD, MSCE; Ronac Mamtani, MD, MSCE; Colleen M. Brensinger, MS; et al.